ORIGINAL RESEARCH
Accepted on 10 Jul 2025
An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies
doi 10.3389/fimmu.2025.1601670
- 247 views